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Traditionally, India holds the unenviable position of the origin
of leprosy. The disease is thought to have then spread, via trade
and war, to China, Egypt, and the Middle East, and later to
Europe and the Americas. From antiquity to modernity, Indian
society treated leprosy singularly with respect to custom and law, a
response shaped by both scientific knowledge and cultural
attitudes. India’s future challenges in leprosy control include
multiple systems of medicine, stigma, and educational knowledge
gaps. By looking through the historical window of leprosy in India,
we propose that continued success in elimination and control
requires a holistic approach addressing these issues (Image 1).
Leprosy in Ancient India
Early texts, including the Atharava Veda (circa 2000 BC) and the
Laws of Manu (1500 BC), mention various skin diseases translated
as leprosy. The Laws prohibited contact with those affected by
leprosy and punished those who married into their families,
effectively ostracizing those with the disease for their past sins [1].
The Sushruta Samhita (600 BC) recommended treating leprosy—or
kushtha, meaning ‘‘eating away’’ in Sanskrit—with oil derived from
the chaulmoogra tree; this remained a mainstay of treatment until
the introduction of sulfones [2].
In a legend explaining chalmoogra oil’s therapeutic origins, a
king banished for his leprosy was instructed to eat the curative
seeds of this tree, illustrating the cultural response to leprosy in
antiquity: loss of social position and expulsion, even of kings, from
the community [3]. Ancient Indian society marginalized those
with leprosy because of several factors: its chronic, potentially
disfiguring nature; inconsistently effective therapy; association with
sin; and the fear of contagion. This combination endowed leprosy
with a unique stigma that persists today and resulted in its
treatment with both seclusion and medical therapy.
Leprosy in Colonial India
Soon after their arrival, Europeans described the uncommon
practice of ritual suicide by those affected by leprosy, who were
often assisted by their families. Though Hinduism generally
considers suicide a sin, for leprosy it was not [4]. Christians too
associated leprosy with sin. Struck by the scale of this Biblical
disease, Europeans, especially missionaries, singled it out from a
myriad of tropical infections. They often described the most
dramatic forms of disfiguring leprosy, evoking fear of an ‘‘imperial
danger’’: leprosy reaching the British Isles. The public pressured
the colonial government for the segregation of people with leprosy.
Three events over a 30-year period strengthened the argument
for confinement. First, the first leprosy census in 1872 quantified
the problem: over 108,000 cases, for a prevalence of 54 cases/
10,000 population. Approximately 1% received organizational
support, renewing the cries for segregation to facilitate delivery of
care [5]. Next, Hansen identified Mycobacterium leprae in 1873 and
postulated it as the etiologic, transmissible agent of leprosy. Third,
Father Damien, the Belgian missionary priest in Hawaii,
contracted leprosy and died in 1889, proving its contagiousness.
These events led to the popular consideration of leprosy as a
widespread contagious disease requiring containment.
In response, the British government sent its Leprosy Commission
(comprising both physicians and administrators) to India to investi-
gate. The commission’sreport in1891 concluded that ‘‘the amountof
contagion which exists is so small that it may be disregarded’’ [6].
Initially, the colonial government accepted these findings but, under
increasing popular pressure from England and within India, enacted
the Leprosy Act of 1898. This law institutionalized people with
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self-sufficient individual with leprosy, segregation and medical
treatment were voluntary, but vagrants and fugitives from govern-
ment-designated leprosaria were subject to punitive action. Charities
and local governments in British India constructed many new
institutions for people with leprosy, providing combined social,
religious, and medical services. However,as predicted by the Leprosy
Commission, the lack of infrastructure prevented the Leprosy Act
from being strictly enforced. It was repealed in 1983 after the advent
of effective multi-drug therapy for leprosy.
Leprosy in Post-Colonial India
Disease control marked the Indian government’s initial
approach, starting in 1955 with the creation of the National
Leprosy Control Program for surveillance. In 1983, with the
availability curative multi-drug therapy, the government changed
the name to the National Leprosy Elimination Program (NLEP),
with a focus on treatment. Starting in 1997, the government
conducted several modified leprosy elimination campaigns; these
short, concentrated bursts of statewide case detection activities
included orientation of all village-level workers and volunteers on
leprosy, house-to-house searches in specified areas, and awareness
programs using mass media, school activities, and community
meetings. State governments also began integrating leprosy care
into their general health systems starting in 1997, moving from
vertical control programs to horizontal health services, an
intervention shown to decrease the stigma associated with leprosy
due to family counseling and community outreach [7].
On January 30, 2005 India celebrated the elimination of leprosy
as a public health problem after achieving the nationwide
prevalence of ,1 case/10,000 population, though not without
criticism regarding the accuracy and choice of target parameter
[8]. This is a remarkable achievement given that in 1981, two
years before NLEP, there were nearly 4,000,000 cases with a
prevalence of .50 cases/10,000 population [9]. However, in a
population of more than a billion people, up to 100,000 people
with leprosy remain, representing approximately half of the
world’s disease burden. Some regions, mostly rural, still have up to
five times the national average of cases; these areas have become
the next targets in leprosy control [10].
The future of leprosy control and elimination offers several
challenges with both structural and cultural dimensions. Efforts to
decrease health inequity due to poverty, especially in rural areas
with limited access to health care, may help with leprosy control.
However, if cultural beliefs are not addressed, increased
availability may not translate into an appropriate increase in
utilization. Cultural aspects of leprosy affecting its control include
traditional medicine and stigma.
Only limited efforts have been made to include the numerous
nonallopathic (traditional) practitioners in India in leprosy control
and elimination efforts, but their inclusion is important to its
success [11]. Indians can seek public or private health care from
allopathic (conventional Western) physicians, but often see private
practitioners of homeopathy or the three major Indian systems of
medicine (ISM) including Ayurveda, Siddha, and Unani. The
practitioners of ISMs, who outnumber allopaths in India, continue
to use compounded botanicals and agents such as chaulmoogra oil
for primary or adjunctive therapy. If this therapy fails, patients are
referred to government clinics where free multi-drug allopathic
therapy is offered; use of traditional medicine has been shown to
be a risk factor for delay in diagnosis [12]. The popularity of ISM
can, as least in part, be attributed to two factors: the stigma carried
by government-run vertical leprosy clinics and the preference for
traditional medicine. Further investigation into the safety and
efficacy of ISM therapies is needed, and the possibility of
integrating aspects of ISM into the general health system should
be evaluated. For example, chalmoogra oil may be effective as
adjunctive therapy in wound healing [13]. The effectiveness of
leprosy control in this integrated system should be periodically
assessed not only in measures of leprosy rates, but of changes in
knowledge, attitudes, and practices.
Leprosy continues to be stigmatized in a society with a deeply
ingrained, though legally abolished, caste system, partly through
lack of knowledge. Socially marginalized groups such as women,
‘‘backward classes’’ (minority social or ethnic groups defined by
the government), and the urban poor are less likely to seek care;
they often view elimination efforts as problematic because they fail
to account for their individual needs [14]. Further, community
education and medical knowledge of the disease does not
immediately dispel stigma. In one community, only 30% of
individuals claiming a high knowledge of leprosy also had a
positive attitude toward patients with leprosy [15]. More studies
are needed to better understand the causes of stigma and to assess
the effect of interventions to decrease it.
Hansen’s disease is still called kusht in most Indian languages, as it
was in Sushrutha’s time.The word itself still evokes fearand aversion,
despite Mohandas ‘‘Mahatma’’ Gandhi’s efforts to destigmatize the
disease. Parchure Shastri, a Brahmin and Sanskrit scholar who
became an outcast when he acquired leprosy, came to stay in
Gandhi’s ashram in 1939. His contemporaries considered sheltering or
touching a person with leprosy unthinkable, but Gandhi changed
Shastri’s wound dressings and massaged his feet daily. This iconic
image (http://commons.wikimedia.org/wiki/Image:Gandhi_leper.
jpg) was later depicted on a postage stamp emblazoned with the
words ‘‘leprosy is curable.’’ The cultural shift Gandhi desired is
materializing; in 2005, representatives of the estimated 630 leprosy
colonies in India met in New Delhi. Entitled ‘‘Empowerment of
PeopleAffected by Leprosy,’’ this conference sought to demarginalize
those affected by the disease and reintegrate them into society.
Conclusions
The history of leprosy in India offers insights into one of the
world’s most misunderstood diseases. Furthermore, leprosy control
and elimination in India still faces many challenges. Although
many of the theoretical and practical approaches of the past have
been discarded, their careful examination provides insights for the
future. Sustaining the gains made so far and further reducing the
disease burden in India require an innovative, holistic approach
that includes ongoing education, efforts to identify interventions to
dispel stigma, and the inclusion of nonallopathic practitioners in
disease control programs.
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